EPIPAGE2 Cohort Study Follow up at Five and a Half Years
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Mar 7, 2017
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • initially included in EPIPAGE 2 cohort or complementary studies or Elfe cohort study
- • family agreement to participate to cohort follow up
- • informed consent form signed by both parents
- • affiliated to social security system
- Exclusion Criteria:
- • parental refusal
- • not affiliated to any social security system
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Caen, , France
Nantes, , France
Amiens, , France
Paris, , France
Besançon, , France
Lille, , France
Clermont Ferrand, , France
Brest, , France
Angers, , France
Montpellier, , France
Valenciennes, , France
Mont De Marsan, , France
Pau, , France
Arras, , France
Lens, , France
Mulhouse, , France
Metz Tessy, , France
Creil, , France
Douai, , France
Roubaix, , France
Cahors, , France
Orléans, , France
Chambery, , France
Haguenau, , France
Colmar, , France
Compiègne, , France
Caen, Normandie, France
Agen, , France
Albi, , France
Auch, , France
Basse Terre, , France
Bayonne, , France
Beauvais, , France
Bordeaux, , France
Bourg En Bresse, , France
Brioude, , France
Bron, , France
Cahors, , France
Calais, , France
Carcassonne, , France
Castres, , France
Cayenne, , France
Chalon Sur Soane, , France
Chambéry, , France
Charleville Mézières, , France
Contamine Sur Arve, , France
Corbeil, , France
Dax, , France
Dijon, , France
Elesme, , France
Epinal, , France
Espaly, , France
Essey Les Nancy, , France
Forbach, , France
Gernoble, , France
Laon, , France
Le Mans, , France
Les Abymes, , France
Lille, , France
Limoges, , France
Lorient, , France
Marseille, , France
Marseille, , France
Metz, , France
Montauban, , France
Montauban, , France
Montivilliers, , France
Montpellier, , France
Mâcon, , France
Nancy, , France
Nancy, , France
Nice, , France
Nîmes, , France
Paris, , France
Perpignan, , France
Périgueux, , France
Reims, , France
Rennes, , France
Reunion, , France
Rodez, , France
Rouen, , France
Saint Brieuc, , France
Saint Denis De La Réunion, , France
Saint Laurent Du Maroni, , France
Saint Pierre, , France
Saint Priesr En Jarez, , France
Saint Quentin, , France
Strasbourg, , France
Tarbes, , France
Thionville, , France
Thionville, , France
Toulouse, , France
Toulouse, , France
Tours, , France
Troyes, , France
Valence, , France
Vannes, , France
Villefranche Sur Saône, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials